medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2011, Number 01

<< Back Next >>

Ginecol Obstet Mex 2011; 79 (01)

Node status in 454 ductal breast cancers cases according to the association with in situ component

Carabias-Meseguer P, Cusidó-Gimferrer M, Zapardiel-Gutiérrez I, Tresserra-Casas F, Fábregas-Xauradó R, Xercavins-Montoya J

Language: Spanish
References: 13
Page: 5-10
PDF size: 311.26 Kb.


ABSTRACT

Background: Studies have shown that breast infiltrating ductal carcinoma develops from precursor lesions or pre-invasive. It is accepted that the risk of invasive ductal carcinoma increased slightly in hyperplasia, but especially in cases of atypical hyperplasia and intraductal carcinoma.
Objectives:To evaluate and compare the nodal status between ductal breast cancer with in situ component (group 1) or without it (group 2).
Material and method: Descriptive and retrospective study that included 454 ductal breast cancers. Data concerning clinical and pathological variables was collected. All data was compared between both groups.
Results: Among all cases, 176 (38.8%) showed positive lymph nodes, 136 patients (39.5%) from group 1 and 40 cases (36.4%) from group 2. Among group 1 cases, high-grade subgroup showed higher positive lymph node rate (82 cases, 55.4%) than the extensive in situ carcinomas subgroup (84 cases, 49.7%). Both of them had a significant higher rate than group 2 cases (p = 0.003 y p = 0.028, respectively). Moreover, the low-grade in situ carcinomas without cellular necrosi had positive lymph nodes just in 30 cases (24%), significantly lower (p = 0.034) than group 2.
Conclusions: We did not find overall statistical differences between groups depending on in situ associated component. But when we analyzed in situ subgroups, we found differences with higher positive lymph node rate in high grade carcinomas and extensive in situ carcinomas subgroups, while lower affectation rates were observed in low grade carcinomas (without cellular necrosis), compared to the group of breast cancers without in situ component associated.


REFERENCES

  1. Dupont WD, Anderson TJ, Rogers LW. Epithelial hyperplasia. In: Page DL, Anderson TJ, editors. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987;p:120- 156.

  2. Tresserra F, Grasses PJ, Garrido M. Lesiones hiperplásicas y preinvasivas precursoras del cáncer de mama: desde la epiteliosis hasta la neoplasia ductal intraepitelial. Rev Senología Patol Mam 2006;19:162-164.

  3. Connolly JL, Boyages J, Schnitt SJ, Recht A, et al. In situ carcinoma of the breast. Annu Rev Med 1989;40:173-180.

  4. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Eng J Med 1985;312:146- 151.

  5. Tresserra F, Martínez MA. Factores pronósticos en el cáncer de mama: parte I. Factores morfológicos. Rev Senología Patol Mam 2008;21:170-174.

  6. Elling D, Vesper AS, Fiedler B, Martin H, Krocker J. Intraductal component in invasive breast cancer: analysis of 250 resected surgical. Breast 2001;10(5):405-410.

  7. Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27(10):1615-1620.

  8. Dzierzanowski M, Melvilla KA, Barnes PJ, Macintosh RF, et al.Ductal carcinoma in situ in core biopsies containing invasive breast cancer correlation with extensive intraductal component and lumpectomy margins. J Surg Oncol 2005;90:71-76.

  9. Garami Z, Sula K, Fulop B, Lukács G, Damjanovich L. Significance of the intraductal component in local recurrences after breast-conserving surgery. Magy Seb 2008;61(1):12-17.

  10. Moulis S, Sgroi DC. Re-evaluating early breast neoplasia. Breast Cancer Res 2008;10:302.

  11. O’Malley FP, Pinder SE. Breast pathology. 1st ed. Philadelphia: Elsevier, 2006.

  12. Jeffrey SS, Pollack JR. The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res 2003;5(6):320-328.

  13. Polyak K. On the birth of breast cancer. Biochim Biophys Acta 2001;1552(1):1-13.




2020     |     www.medigraphic.com